Preoperative MRI Offers No Survival Benefit for Early-Stage Breast Cancer Patients

Pre-Op MRI Shows 'No Clinical Benefit' in Early Breast Cancer

(MedPage Today) -- SAN ANTONIO -- Preoperative MRI for staging patients with early, hormone receptor (HR)-negative breast cancer didn't result in improved oncologic outcomes or improved clinical care, according to a phase III study presented...

Preoperative MRI offers no survival benefit for early-stage breast cancer patients

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance imaging (MRI) in addition to diagnostic mammography to determine the extent of their cancer, according to results from the phase III Alliance A011104/ACRIN 6694 clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December …

Preoperative MRI Staging Does Not Improve Outcomes in Early Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

New research reveals that preoperative breast MRI does not enhance outcomes for early-stage breast cancer patients, challenging its routine use in treatment plans.

Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer

The 60-month local regional recurrence-free rate was 93.2% in the MRI arm versus 95.7% in the no MRI arm, researchers reported.

Resecting MRI-Detected Disease Doesn’t Improve Outcomes in Early-Stage BC

The 60-month local regional recurrence-free rate was 93.2% in the MRI arm vs 95.7% in the no MRI arm among patients with newly diagnosed breast cancer.